Today: 12 May 2026
Axe Compute (AGPU) stock in focus after biggest-ever $260 million Nvidia B300 contract
22 April 2026
2 mins read

Axe Compute (AGPU) stock in focus after biggest-ever $260 million Nvidia B300 contract

PITTSBURGH, April 22, 2026, 09:15 EDT.

  • Axe Compute locked in a 36-month enterprise agreement worth about $260 million, supplying 2,304 Nvidia B300 GPUs and fast storage to an unnamed client.
  • Slated for launch in the third quarter of 2026, the plan calls for a U.S. Tier 3 data center. The terms? Deposit up front, prepayment, then monthly advances, according to the agreement.
  • Axe signed the deal just weeks after revealing 2025 revenue of $125,284, with the company also confirming that so far, none of its new AI infrastructure business has produced compute revenue.

Axe Compute (AGPU) landed what it described Wednesday as its largest deal so far: a $260 million enterprise contract spanning 36 months. Per the filing, the agreement will see Axe supply 2,304 Nvidia B300 GPUs along with high-speed storage to an undisclosed enterprise client.

This marks a crucial win for Axe. The Pittsburgh outfit—once Predictive Oncology—is still scrambling to turn its strategy pivot into something tangible on the top line. Revenue for 2025 came in at just $125,284, entirely from its legacy drug-discovery business. Not a dollar from compute yet.

The crunch comes while AI players chase compute wherever they can find it. CoreWeave and Nebius, as Reuters pointed out this week, are now tied to multibillion-dollar infrastructure deals. Morgan Stanley, in a recent note, called attention to a new trend: “As AI transitions from generation to autonomous action, the computing bottleneck is shifting towards CPU and memory,” the firm wrote. Still, appetite for GPUs hasn’t faded. Reuters

Axe aims to start rolling out its plan in the third quarter of 2026, with a focus on a single U.S. Tier 3 data center. These sites are classified in the industry for their fully redundant design—systems stay up even during maintenance. The build will feature 4.8 megawatts of dedicated power and backup redundancy as standard.

First, there’s an upfront deposit, followed by prepayment, with monthly advance fees after that. The structure is take-or-pay—buyers owe for all reserved capacity whether they use it or not. The contract runs for three years and gives the buyer renewal rights.

“This agreement is a signal,” said Chief Executive Christopher Miglino. He insisted companies have moved past shaping AI strategies around the boundaries set by big cloud providers. To Miglino, the contract shows that buyers are willing to spend for U.S.-based dedicated infrastructure instead of waiting their turn for shared cloud resources. GlobeNewswire

This update builds on Axe’s previous, smaller disclosures. On April 1, the company said it had secured roughly $12 million in signed agreements with more than 20 enterprise customers, putting projected monthly revenue at around $835,000 once those deployments go live. At that point, Miglino stressed the book was “not a marketing milestone.” GlobeNewswire

Axe flagged in its annual report that unlike the major AI-cloud names, it’s skipping data centers and GPU hardware altogether. The company’s leaning into an asset-light marketplace model instead. That keeps capital outlays low, but it also means Axe depends on third-party infrastructure for the nuts and bolts of its operations.

Nvidia’s B300, part of the Blackwell Ultra lineup, is designed for everything from model training to real-time inference—turning machine learning into output. Axe has deployed Nvidia’s newest, but it’s still behind a competitor that overhauled its brand only in December and is deep into a pivot toward AI infrastructure.

That $260 million figure isn’t a sure thing just yet. Axe pointed out a tangle of uncertainties: the final amount hinges on contract details, and there are plenty of risks—think execution hiccups, enforceability concerns, supply-chain snags, ramp-up speed for facilities, whether customers stick to their commitments, and competition—that could reduce the payout or drag out the timeline.

Last month, Miglino summed it up: “Our priorities for 2026 are driving revenue and growth.” Simple in theory, but the real challenge is ahead—deploying 2,304 B300 GPUs as scheduled and making sure that newly inked contract actually hits the revenue line. SEC

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
SoundHound AI Stock Rebounds After $43 Million LivePerson Deal as Investors Reassess the Selloff
Previous Story

SoundHound AI Stock Rebounds After $43 Million LivePerson Deal as Investors Reassess the Selloff

Why Strategy Stock (MSTR) Is Outpacing Bitcoin Again After a $2.54 Billion Buy
Next Story

Why Strategy Stock (MSTR) Is Outpacing Bitcoin Again After a $2.54 Billion Buy

Go toTop